SSL: Systems Saving Lives - Long-term Survival of Out-of-hospital Cardiac Arrest in the Urban Area of Bologna

Sponsor
Azienda Usl di Bologna (Other)
Overall Status
Recruiting
CT.gov ID
NCT04510480
Collaborator
(none)
5,000
1
66
75.8

Study Details

Study Description

Brief Summary

Evaluation of clinical, logistical, and technical factors (e.g. implementation of pre-arrival instructions, implementation of the DAE RespondER, mechanical chest compressor, REBOA, and E-CPR) that impact on the outcomes of out-of-hospital cardiac arrest patients.

Condition or Disease Intervention/Treatment Phase
  • Other: Observational study without specific intervention

Study Design

Study Type:
Observational
Anticipated Enrollment :
5000 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Systems Saving Lives - Long-term Survival of Out-of-hospital Cardiac Arrest in the Urban Area of Bologna Following the Implementation of the Pre-arrival Instructions, the DAE RespondER, Mechanical Chest Compressors and Circulatory Support With REBOA and ECMO
Actual Study Start Date :
Jul 1, 2020
Actual Primary Completion Date :
Jul 1, 2021
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
cardiac arrest

Out of hospital cardiac arrest patients (Historical cohort) from 1st January 2009 and 30th June 2020. Out of hospital cardiac arrest patients from 1st July 2020 and 31st December 2025.

Other: Observational study without specific intervention
Observational study with standard cardiac arrest approach

Outcome Measures

Primary Outcome Measures

  1. ROSC (Return of spontaneous circulation) [1st July 2020 to 31st December 2025]

    ROSC (Return of spontaneous circulation) of cardiac arrest patients

  2. Hospital admission status [1st July 2020 to 31st December 2025]

    Hospital admission status of cardiac arrest patients

  3. Hospital discharge status/survival at 30 days [30 days]

    Hospital discharge status/survival at 30 days of cardiac arrest patients

Secondary Outcome Measures

  1. Survival at 6 months [6 months]

    Survival at 6 months of cardiac arrest patients

  2. Survival at 1 years [1 year]

    Survival at 1 years of cardiac arrest patients

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 120 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Out of Hospital cardiac arrest patients (historical cohort) from 1st January 2009 and 30th June 2020

  • Out of Hospital cardiac arrest patients from 1st July 2020 and 31st December 2025

Exclusion Criteria:
  • False cardiac arrest

  • In-hospital cardiac arrest

Contacts and Locations

Locations

Site City State Country Postal Code
1 Maggiore Hospital Ospedale Maggiore Carlo Alberto Pizzardi AUSL di Bologna Bologna Italy 40110

Sponsors and Collaborators

  • Azienda Usl di Bologna

Investigators

  • Principal Investigator: Federico F Semeraro, MD, FERC, Maggiore Hospital Carlo Alberto Pizzardi AUSL di Bologna

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Azienda Usl di Bologna
ClinicalTrials.gov Identifier:
NCT04510480
Other Study ID Numbers:
  • 1.0
First Posted:
Aug 12, 2020
Last Update Posted:
Feb 16, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 16, 2022